Orchid Pharma Limited

NSE:ORCHPHARMA.NS

1403.1 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q12018 Q22013 Q22011 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 2,665.651-503.634404.192-266.117225.971-126.89145.891-43.12543.066-205.717118.792-315.147156.939-641.96167.547-1,759.2898.915-3,286.3031,143.902234.2351,785.952
Short Term Investments 2,674.691,007.268149.344532.23481.875253.78281.69686.255.204411.43487.229630.294158.2081,283.92476.5623,518.40.1226,572.6062,297.74800
Cash and Short Term Investments 2,665.651503.634553.536266.117307.846126.891127.58743.12548.27205.717206.021315.147315.147641.96644.1091,759.2899.0373,286.3033,441.65234.2351,785.952
Net Receivables 1,955.47101,884.59102,161.47502,149.40602,665.15501,774.02603,584.71301,561.25103,326.16701,284.52401,132.37
Inventory 2,642.26102,223.60702,287.3802,360.19501,726.56301,864.4901,528.85302,056.60501,557.09301,737.6275,062.3936,687.254
Other Current Assets 644.1180312.2970253.3960319.971058.870348.702069.85801,044.598089.860662.0735,208.6983,797.53
Total Current Assets 7,907.501503.6344,974.031266.1175,010.097126.8914,957.15943.1254,498.858205.7174,193.239315.1475,498.571641.965,306.5631,759.25,872.1573,286.3037,125.87410,505.32613,403.106
Non-Current Assets:
Property, Plant & Equipment, Net 6,359.86906,224.76106,191.71906,156.79406,048.19106,395.36306,775.074010,403.761010,987.722014,616.47928,548.15223,732.391
Goodwill 0000000000000000000948.233986.125
Intangible Assets 149.185050.16103.85704.12903.37303.52903.6860274.7820286.3440358.9510798.355
Goodwill and Intangible Assets 149.185050.16103.85704.12903.37303.52903.6860274.7820286.3440358.951948.2331,784.48
Long Term Investments 517.87602,914.3230444.4130435.4920449.7780420.5470-154.0310-425.24903.260-2,116.1700
Tax Assets -00662.3590581.763065.080828.347087.2290198.0470476.562070.64702,297.74800
Other Non-Current Assets 604.308-503.63495.208-266.11720.214-126.89134.582-43.125-722.922-205.71750.156-315.14751.174-641.9651.066-1,759.2-3.572-3,286.3038,068.3986,051.664943.641
Total Non-Current Assets 7,631.238-503.6349,946.812-266.1177,241.966-126.8916,696.077-43.1256,606.767-205.7176,956.824-315.1476,873.95-641.9610,780.922-1,759.211,344.401-3,286.30323,225.40635,548.04926,460.512
Total Assets 15,538.739014,920.843012,252.063011,653.236011,105.625011,150.063012,372.521016,087.485017,216.558030,351.28246,053.37539,863.613
Liabilities & Equity:
Current Liabilities:
Account Payables 2,295.76902,253.71501,817.8501,777.45901,676.8301,208.45401,099.52401,316.34801,034.35102,829.4765,220.644,006.637
Short Term Debt 143.808098.6201,825.08101,303.1540597.8840386.70252.426044.0070624.22406,961.25915,248.9489,310.786
Tax Payables 000000000000000000000
Deferred Revenue 19.466011.297034.86046.5370123.23047.912060.907051.019087.473011.177177.2071,642.546
Other Current Liabilities 140.7026.483041.126076.20909.839061.80107.9610414.428062.114010,491.15810,016.72887.138
Total Current Liabilities 2,599.74302,390.11503,718.91703,203.35902,407.78301,704.86701,420.81801,825.80201,808.162020,293.0730,663.52315,047.107
Non-Current Liabilities:
Long Term Debt 1,204.29801,375.23101,488.37602,089.98102,081.65202,565.01904,274.97404,321.97905,014.707017,817.5359,017.94110,741.47
Deferred Revenue Non-Current -1,108.1420001,614.39402,200.1100000-2,955.2860-2,993.8860-3,388.3940-8,059.06252.39877.197
Deferred Tax Liabilities Non-Current 1,108.142032.262032.262032.262032.262032.262032.262032.262032.262032.2621,573.7011,700.741
Other Non-Current Liabilities 40.037044.8290-1,488.3760-2,089.9810110.1290115.38903,070.67503,111.7403,506.24808,136.144887.893463.408
Total Non-Current Liabilities 1,244.33501,452.32201,646.65602,232.37202,224.04302,712.6704,422.62504,472.09505,164.823017,926.87911,531.93312,982.816
Total Liabilities 3,844.07803,842.43705,365.57305,435.73104,631.82604,417.53705,843.44306,297.89706,972.985038,219.94942,195.45628,029.923
Equity:
Preferred Stock 000000000000000000000
Common Stock 507.1910507.1910408.1640408.1640408.1640408.1640408.1640408.1640408.1640889.643704.521704.421
Retained Earnings -21,765.246000-22,682.405000-23,143.26000-20,301.744000-19,142.429000362.744
Accumulated Other Comprehensive Income/Loss 23,801.9311,078.40610,571.2156,886.4923,830.3396,217.5055,809.3416,473.79923,878.5036,732.5266,324.3626,529.0785,052.959,789.5889,381.42410,243.57416,164.137-7,040.375000
Other Total Stockholders Equity 9,150.7860005,330.3920005,330.39200021,369.70800012,813.7010-8,758.313,147.20710,738.297
Total Shareholders Equity 11,694.66111,078.40611,078.4066,886.496,886.496,217.5056,217.5056,473.7996,473.7996,732.5266,732.5266,529.0786,529.0789,789.5889,789.58810,243.57410,243.573-7,040.375-7,868.6673,851.72811,805.462
Total Equity 11,694.66111,078.40611,078.4066,886.496,886.496,217.5056,217.5056,473.7996,473.7996,732.5266,732.5266,529.0786,529.0789,789.5889,789.58810,243.57410,243.573-7,040.375-7,868.6673,857.91911,833.69
Total Liabilities & Shareholders Equity 15,538.73911,078.40614,920.8436,886.4912,252.0636,217.50511,653.2366,473.79911,105.6256,732.52611,150.0636,529.07812,372.5219,789.58816,087.48510,243.57417,216.558-7,040.37530,351.28246,053.37539,863.613